Lipoprotein lipase gene polymorphism and lipid profile in coronary artery disease

被引:0
|
作者
Duman, BS
Türkoglu, C
Akpinar, B
Güden, M
Vertii, A
Dak, E
Çagatay, P
Günay, D
Büyükdevrim, AS
机构
[1] Kadir Has Univ, Sch Med, Dept Med Biol & Genet, TR-80810 Istanbul, Turkey
[2] Kadir Has Univ, Sch Med, Dept Cardiol, TR-80810 Istanbul, Turkey
[3] Kadir Has Univ, Sch Med, Dept Heart & Vasc Surg, TR-80810 Istanbul, Turkey
[4] Istanbul Univ, Cerrahpasa Med Sch, Dept Biostat, Istanbul, Turkey
[5] Florence Nightingale Hosp, Biochem Lab, Istanbul, Turkey
[6] Florence Nightingale Hosp, Dept Diabetol & Metab Disorders, Istanbul, Turkey
关键词
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Context.-Lipoprotein lipase (LPL) plays a central role in lipid metabolism, hydrolyzing triglyceride in chylomicrons and very-low-density lipoproteins. The PvuII polymorphic variant of LPL gene is common and might affect risk of coronary artery disease (CAD). Objective.-Our aim was to determine whether LPL-PvuII polymorphism can be considered to be an independent risk factor or a predictor for CAD in Turkish subjects. Design.-We used polymerase chain reaction and restriction enzyme digestion to determine the distribution of the previously described C-->T transition that causes a PvuII polymorphism in intron 6 among healthy blood donors of Turkish origin and among angiographically confirmed CAD patients with comparable ethnic backgrounds. Results.-For the PvuII genotypes, within the CAD group (n = 80), the +/- genotype was found in 39 individuals (48.8%), whereas 25 (31.3%) carried the +/+ genotype, and 14 (17.5%) carried the -/- genotype. Within the control group (n = 49), the -/- genotype was found in 19 individuals (38.8%), 16 (32.7%) carried the +/- genotype, and 14 (28.6%) carried the +/+ genotype. The genotype frequency distribution was significantly different (P = .049) in the CAD and control study groups. The most frequent genotype among CAD patients was +/-; this genotype was more frequent in patients than in control subjects. However, the -/- genotype was more prevalent in the control group. Lipoprotein lipase-PvuII polymorphism was found to be associated with fasting total cholesterol and low-density lipoprotein cholesterol levels. The +/+ genotype was found to have higher levels of total cholesterol and low-density lipoprotein cholesterol in both the CAD and control groups. Conclusion.-There was a difference in the distribution of LPL-PvuII genotypes between the healthy subjects and the patients with CAD. Lipoprotein lipase-PvuII polymorphisms were not detected as independent risk factors for CAD in this study group, but had associations with lipid levels.
引用
收藏
页码:869 / 874
页数:6
相关论文
共 50 条
  • [41] Serum lipoprotein lipase concentration and risk for future coronary artery disease
    Rip, J
    Nierman, MC
    Wareham, NJ
    Luben, R
    Bingham, SA
    Day, NE
    van Miert, JNI
    Hutten, BA
    Kastelein, JJP
    Kuivenhoven, JA
    Khaw, KT
    Boekholdt, SM
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2006, 26 (03) : 637 - 642
  • [42] Regulatory mutations in the human lipoprotein lipase gene in patients with familial combined hyperlipidemia and coronary artery disease
    Yang, WS
    Nevin, DN
    Iwasaki, L
    Peng, RL
    Brown, BG
    Brunzell, JD
    Deeb, SS
    JOURNAL OF LIPID RESEARCH, 1996, 37 (12) : 2627 - 2637
  • [43] Impact of serum levels of lipoprotein lipase, hepatic lipase, and endothelial lipase on the progression of coronary artery disease
    Hui Han
    Daopeng Dai
    Wencheng Wang
    Jinzhou Zhu
    Zhengbin Zhu
    Lin Lu
    Ruiyan Zhang
    Journal of Interventional Medicine, 2019, 2 (01) : 16 - 20
  • [44] AN ALLELE AT THE LIPOPROTEIN-LIPASE (LPL) GENE LOCUS ASSOCIATES WITH CORONARY-ARTERY DISEASE (CAD)
    CHAMBERLAIN, JC
    THORN, JA
    MORGAN, R
    BISHOP, A
    REES, A
    STOCKS, J
    GALTON, DJ
    ATHEROSCLEROSIS, 1990, 85 (01) : 96 - 96
  • [45] Prevalence of microalbuminuria, lipoprotein (a) and coronary artery disease in the lipid clinic
    Cummings, MH
    Watts, GF
    Tavakolian, A
    Fitzgerald, A
    JOURNAL OF CLINICAL PATHOLOGY, 1996, 49 (01) : 19 - 23
  • [46] Lipid profile in Egyptian patients with coronary artery disease
    Ibrahim, M. Mohsen
    Ibrahim, Ahmed
    Shaheen, Khaldoon
    Nour, Mona A.
    EGYPTIAN HEART JOURNAL, 2013, 65 (02): : 79 - 85
  • [47] Lipid profile in the acute phase of coronary artery disease
    Batalla, A
    Reguero, JR
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2001, 80 (2-3) : 265 - 265
  • [48] Abnormal Lipid Profile in Patients with Coronary Artery Disease
    Cheema, Hina Aslam
    Ijaz, Farrukh
    Zahra, Maliha Tul
    Memon, Abeer
    Hussain, Wajid
    PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2021, 15 (04): : 1206 - 1208
  • [49] CORRELATION OF LIPID PROFILE AND LIPOPROTEIN RATIOS WITH ANGIOGRAPHICALLY SIGNIFICANT CORONARY ARTERY DISEASE: A RETROSPECTIVE DESCRIPTIVE STUDY
    Navarro, F. J.
    Ramboyong, R. E.
    CARDIOLOGY, 2017, 137 : 325 - 325
  • [50] Lipoprotein lipase HindIII polymorphism influences HDL-cholesterol in statin-treated patients with coronary artery disease
    Javorsky, M.
    Gasperikova, D.
    Ukropec, J.
    Sedlakova, B.
    Riecansky, I.
    Krizanova, O.
    Sebokova, E.
    Dobrikova, M.
    Klimes, I.
    Tkac, I.
    DIABETOLOGIA, 2007, 50 : S511 - S511